SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shorter radiation regimen aims to improve sarcoma treatment
Disease control Recruiting nowThis phase 2 trial is testing a shorter, more intense radiation schedule given before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal is to see if this approach can keep the cancer from coming back in the same spot. About 135 adults will receive 15 radiation…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Immunotherapy-Chemo combo takes on advanced sarcoma
Disease control Recruiting nowThis study tests whether adding an experimental immunotherapy drug called retifanlimab to standard chemotherapy (gemcitabine and docetaxel) is safe and effective for people with advanced soft tissue sarcoma that cannot be removed by surgery. About 98 participants will receive the…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Proton beam boost: new hope for inoperable sarcomas?
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control inoperable soft tissue sarcomas without increasing side effects. Forty adults with these rare tumors will receive targeted radiation over 4 weeks. Researchers will also look at blood and imaging markers…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized 3-week course of proton radiation before surgery for soft tissue sarcoma can reduce long-term side effects compared to standard X-ray radiation. About 110 adults in Norway will receive either proton or X-ray therapy, chosen individually for…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to stall sarcomas in tough cases
Disease control Recruiting nowThis study tests two drugs, pembrolizumab and cabozantinib, together in people with advanced sarcomas (cancers of the soft tissue or bone) that have not responded to standard treatments. The goal is to see if the combination can stop or shrink tumors for at least 6 months. About …
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
800-Patient study aims to tailor sarcoma treatment
Knowledge-focused Recruiting nowThis study is collecting tissue samples and medical data from 800 high-risk sarcoma patients to develop personalized treatment approaches. Researchers will analyze genetic and protein profiles to better predict which patients benefit from chemotherapy before surgery. The goal is …
Matched conditions: SOFT TISSUE SARCOMA ADULT
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC